Improving the production and stability of nanobodies
Protein Engineering, Design and Selection · 10.01.2025 · 38
DOI: 10.1093/protein/gzaf010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Engineering, Design and Selection, online erschienen am 23.09.2025. Verfasst von Alba Pejenaute und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cooperative Research in Biosciences CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Buil…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Protein Engineering. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Agencia Estatal de Investigación, Basque Foundation for Science.
Abstract (Originalsprache)
Nanobodies offer unique advantages in biomedical and biotechnological applications due to their smaller size, ability to bind challenging epitopes, and affordable production using recombinant technology. However, challenges in large-scale production, stability, and solubility limit their widespread use. To address this, we use artificial intelligence tools to optimize the scaffold region of nanobodies. We apply our approach to four nanobodies against clinically relevant targets: the cytokine tumor necrosis factor alpha, the chemotherapeutic drug methotrexate, the pancreatic biomarker amylase, and the placental hormone chorionic gonadotropin. For all the nanobodies tested, we improve stability, production, and intracellular stability while maintaining antigen-binding affinity. Our results thus demonstrate the potential for using AI-driven protein engineering to enhance the properties of nanobodies, offering insights into the interplay between stability, solubility, and antigen binding. Given the high conservation of the scaffold, we propose some mutations that could directly transfer to other nanobodies, providing an easy-to-implement, generalizable engineering strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cooperative Research in Biosciences CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bizkaia Science and Technology Park, Building 800, 48160 Derio, Spain.
- Tekniker, Basque Research and Technology Alliance (BRTA), C/ Iñaki Goenaga 5, 20600 Eibar, Spain.
- Centro de investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de salud Carlos III, Av. Monforte de Lemos 3-5, Pabellón 11, Planta 0, 28029 Madrid, Spain.
- Ikerbasque, Basque Foundation for Science, Plaza Euskadi 5, 48009 Bilbao, Spain.
ORCID-Profile: Gabriel Ortega-Quintanilla
Förderung
- Spanish Agencia Estatal de Investigación
- Basque Foundation for Science
Zitieren
APA
Pejenaute, A., Gálvez-Larrosa, L., Segovia, C. M., Herrero-Alfonso, P., Fernández-Ramos, D., Lopitz-Otsoa, F., Millet, Ó., Peccati, F., Jiménez-Osés, G., & Ortega-Quintanilla, G. (2025). Improving the production and stability of nanobodies. Protein Engineering, Design and Selection, 38. https://doi.org/10.1093/protein/gzaf010
Vancouver
Pejenaute A, Gálvez-Larrosa L, Segovia CM, Herrero-Alfonso P, Fernández-Ramos D, Lopitz-Otsoa F, et al. Improving the production and stability of nanobodies. Protein Engineering, Design and Selection. 2025;38. doi:10.1093/protein/gzaf010
BibTeX
@article{Pejenaute2025,
author = {Pejenaute, Alba and Gálvez-Larrosa, Laura and Segovia, Cristina M and Herrero-Alfonso, Pablo and Fernández-Ramos, David and Lopitz-Otsoa, Fernando and Millet, Óscar and Peccati, Francesca and Jiménez-Osés, Gonzalo and Ortega-Quintanilla, Gabriel},
title = {Improving the production and stability of nanobodies},
journal = {Protein Engineering, Design and Selection},
year = {2025},
volume = {38},
doi = {10.1093/protein/gzaf010}
}
EUVIMED